Managing the Final Mile: Preparing Hospitals for Widespread Commercial CGT Product Integration
Wednesday, May 29, 2024 09:15 AM - 10:15 AM
Room 201
Clinic & Therapeutic Development
Roundtable
Organized by: ISCT Immuno-Gene Therapy Committee
Moderator
Key Learning Objectives
1. The current workflow for handling of commercial CGT in hospitals in the US and other countries
2. Challenges/pain points in wide adoption of commercial CGT by hospitals
3. The future of CGT final mile: accommodating of growing number of commercial CGT – hospital’s infrastructure and resources readiness
Moderator
- Alexey Bersenev, MD, PhD, Yale University, United States
- Catherine McIntyre, PhD, Stanford Healthcare, United States
- Fermin Sanchez-Guijo, MD, PhD, University Hospital of Salamanca, Spain
- Mark Lowdell, PhD, FRCPath, FRSB, University College London, United Kingdom
- Ronit Slotky, PhD, MSc, CABP, Hackensack University Medical Center, United States
Key Learning Objectives
1. The current workflow for handling of commercial CGT in hospitals in the US and other countries
2. Challenges/pain points in wide adoption of commercial CGT by hospitals
3. The future of CGT final mile: accommodating of growing number of commercial CGT – hospital’s infrastructure and resources readiness
Fermin Sanchez-Guijo
Head Hematology Dpt & Full-Professor of Medicine
Hospital Universitario de Salamanca, Universidad de Salamanca
Panelist
Head Hematology Dpt & Full-Professor of Medicine
Hospital Universitario de Salamanca, Universidad de Salamanca
Panelist